The Israeli trial with cilazapril (Vasocase) for the treatment of hypertension--summary of the care of 413 patients in a community health setting
In a multicenter study in community clinics, 413 patients with mild to moderate essential hypertension were treated with cilazapril (Vasocase), 2.5 mg daily. Patients had either been untreated or had developed side-effects from previous antihypertensive treatment. When response was inadequate the dose was either increased to 5 mg or another antihypertensive medication was added, or both. Treatment significantly reduced systolic and diastolic blood pressures. Pulse rate decreased significantly from the second month of treatment onwards. At the end of the 3rd month of treatment blood pressure was normalized or had decreased by more than 10 mmHg in 91.9% of patients. Physicians' evaluations revealed improvement in 62%; patients' self-evaluations suggested improvement in 61%. Efficacy was equal in all age groups and in both obese and nonobese patients. Antihypertensive response was superior in those with normal renal function. Side-effects were rare and similar to those reported in the literature.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2000 |
---|---|
Erschienen: |
2000 |
Enthalten in: |
Zur Gesamtaufnahme - volume:138 |
---|---|
Enthalten in: |
Harefuah - 138(2000), 5 vom: 01. März, Seite 345-50, 424 |
Sprache: |
Hebräisch |
---|
Beteiligte Personen: |
Zimlichman, R [VerfasserIn] |
---|
Themen: |
19KW7PI29F |
---|
Anmerkungen: |
Date Completed 26.07.2000 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM10807434X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM10807434X | ||
003 | DE-627 | ||
005 | 20231222144421.0 | ||
007 | tu | ||
008 | 231222s2000 xx ||||| 00| ||heb c | ||
028 | 5 | 2 | |a pubmed24n0361.xml |
035 | |a (DE-627)NLM10807434X | ||
035 | |a (NLM)10883128 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a heb | ||
100 | 1 | |a Zimlichman, R |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Israeli trial with cilazapril (Vasocase) for the treatment of hypertension--summary of the care of 413 patients in a community health setting |
264 | 1 | |c 2000 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 26.07.2000 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a In a multicenter study in community clinics, 413 patients with mild to moderate essential hypertension were treated with cilazapril (Vasocase), 2.5 mg daily. Patients had either been untreated or had developed side-effects from previous antihypertensive treatment. When response was inadequate the dose was either increased to 5 mg or another antihypertensive medication was added, or both. Treatment significantly reduced systolic and diastolic blood pressures. Pulse rate decreased significantly from the second month of treatment onwards. At the end of the 3rd month of treatment blood pressure was normalized or had decreased by more than 10 mmHg in 91.9% of patients. Physicians' evaluations revealed improvement in 62%; patients' self-evaluations suggested improvement in 61%. Efficacy was equal in all age groups and in both obese and nonobese patients. Antihypertensive response was superior in those with normal renal function. Side-effects were rare and similar to those reported in the literature | ||
650 | 4 | |a Clinical Trial | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Antihypertensive Agents |2 NLM | |
650 | 7 | |a Cilazapril |2 NLM | |
650 | 7 | |a 19KW7PI29F |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Harefuah |d 1946 |g 138(2000), 5 vom: 01. März, Seite 345-50, 424 |w (DE-627)NLM000070491 |x 0017-7768 |7 nnns |
773 | 1 | 8 | |g volume:138 |g year:2000 |g number:5 |g day:01 |g month:03 |g pages:345-50, 424 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 138 |j 2000 |e 5 |b 01 |c 03 |h 345-50, 424 |